MIRANDA
Who is this for?
Those with symptomatic COPD (have had ≥2 moderate OR ≥ 1 severe exacerbations in the past year)
Study:
This study looks at the drug tozorakimab. It aims to evaluate the safety and efficacy of adding tozorakimab alongside current standard of care medications on improving COPD symptoms.